PTC Therapeutics Appoints Pierre Gravier as CFO
Executive joins PTC with finance strategy experience, particularly as it pertains to biopharma.
PTC Therapeutics, Inc., a biopharma company, has appointed Pierre Gravier to the role of CFO. He brings more than 17 years of experience as an investment banker, venture capitalist, and scientist to PTC. Most recently, Gravier was a managing director in the healthcare group of Perella Weinberg Partners, an independent global advisory firm. At Perella Weinberg, he focused on advising companies in the biopharma and pharma sectors on finance strategy and corporate development.
Prior to joining Perella Weinberg, Pierre worked as a healthcare investment banker at Barclays Capital in London. He was also a venture capital analyst at Société Générale Asset Management in Paris, but began his career as a scientist at Ferring Pharmaceuticals.
"We are incredibly excited to have Pierre as part of PTC's leadership team," comments Matthew B. Klein, MD, CEO, PTC Therapeutics. "Pierre's extensive global experience in finance and healthcare advisory will be incredibly helpful as we continue to build the PTC of tomorrow.”
